Synlogic (SYBX US)

Synlogic, Inc. operates as a pharmaceutical company. The Company develops synthetic biotic medicines for inflammatory bowel diseases, cancer, metabolic diabetes, obesity, metabolic conditions, urea cycle disorders, and other rare genetic disorders. Synlogic serves customers in the United States.